Diagnosis & Investigations of Malaria

Sources: Harrison's Principles of Internal Medicine 22E (2025), Goodman & Gilman's Pharmacological Basis of Therapeutics, Sherris & Ryan's Medical Microbiology 8E, Park's Textbook of Preventive and Social Medicine

Core Principle

Malaria is NOT a clinical diagnosis. Any patient from or returning from a malarious area with fever must have blood smears prepared and examined immediately. A negative smear by an experienced microscopist effectively rules out malaria. - Harrison's, p.1810

1. Peripheral Blood Smear - The Gold Standard

The definitive diagnosis rests on demonstrating asexual forms of the parasite in stained peripheral blood smears.

Staining

Giemsa stain at pH 7.2 - preferred Romanowsky stain
Field's, Wright's, or Leishman's stains are acceptable alternatives
Acridine orange (fluorescent dye) - allows more rapid diagnosis at low-level parasitemia, but cannot identify species

Thick Film vs. Thin Film

Feature	Thick Film	Thin Film
Purpose	Screening / detection	Species identification
Sensitivity	40-100x more concentrated	Lower
Preparation	Dried without fixing	Air-dried, fixed in anhydrous methanol
Examination	Oil immersion after staining unfixed	Oil immersion (x1000)
Result	Parasites per µL (using WBC count)	Parasites per 1000 RBCs

A minimum of 200 WBCs should be counted under oil immersion on the thick film
Before declaring a thick smear negative, examine 100-200 fields
Parasitemia is expressed as parasitized erythrocytes per 1000 RBCs on thin film, or per µL on thick film (assuming WBC 8000/µL if count unavailable)

P. falciparum thin film appearances:

P. falciparum thin blood films - A: young trophozoite, B: old trophozoite, C: trophozoites with pigment in PMNs, D: mature schizont, E: female gametocyte, F: male gametocyte

Fig. 231-4 Thin blood films of P. falciparum - A. Young trophozoite B. Old trophozoite C. Trophozoites with malarial pigment in PMNs D. Mature schizont E. Female gametocyte F. Male gametocyte (Harrison's 22E)

P. vivax thin film appearances:

P. vivax thin blood films - A: young trophozoite, B: old trophozoite, C: mature schizont, D: female gametocyte, E: male gametocyte

Fig. 231-5 Thin blood films of P. vivax - A. Young trophozoite B. Old trophozoite C. Mature schizont D. Female gametocyte E. Male gametocyte (Harrison's 22E)

2. Rapid Diagnostic Tests (RDTs)

When reliable microscopy is unavailable, an RDT must be performed. RDTs detect parasite antigens in finger-prick blood samples:

Antigen Detected	Parasite	Notes
PfHRP2 (histidine-rich protein 2)	P. falciparum only	Remains positive for weeks post-infection - useful in severe malaria after drug clearance; risk of false-negative with PfHRP2/3 gene deletions (increasingly common in Horn of Africa)
pLDH (parasite lactate dehydrogenase)	Pan-malaria or species-specific	Clears more rapidly after treatment
Aldolase	Pan-malaria	Less common

Dual-antibody RDTs (PfHRP2 + pan-malaria or P. vivax-specific) can distinguish falciparum from non-falciparum malaria
Key limitation: RDTs do not quantify parasitemia
Smear should always accompany or follow an RDT to confirm species and assess parasite density

3. Parasitemia Density and Prognosis

>10⁵ parasites/µL - increased risk of death
Non-immune patients may die at lower counts; partially immune individuals may tolerate much higher counts
Poor prognostic signs on smear in P. falciparum:
- 20% of parasites with visible pigment (mature forms)
- Malarial pigment in >5% of neutrophils (indicates recent schizogony)
Gametocytemia of P. falciparum peaks ~1 week after peak of asexual parasitemia; gametocytes persist after treatment - do not indicate treatment failure
Intraphagocytic malarial pigment in monocytes may suggest recent infection even if no live parasites visible

4. Molecular Diagnosis (PCR)

More sensitive than both microscopy and RDTs for detecting parasites and identifying species
Used in reference centres and for confirmation of low-density infections
Not used for primary diagnosis in endemic areas due to cost and turnaround time
Useful for detecting mixed infections, drug-resistance genotyping, and epidemiological studies

5. Supporting Laboratory Investigations

These are not diagnostic but help assess severity:

Investigation	Typical Findings in Malaria
FBC	Anaemia (normocytic), thrombocytopenia
Blood film	Parasitaemia (as above)
Reticulocyte count	Raised (haemolytic anaemia)
LFTs	Raised bilirubin (jaundice from haemolysis), elevated transaminases
RFTs	Raised creatinine/urea in severe disease (acute kidney injury)
Blood glucose	Hypoglycaemia - especially with P. falciparum or quinine treatment
Coagulation screen	DIC in severe falciparum malaria
Blood cultures	To exclude co-infection with bacteraemia
Urinalysis	Haemoglobinuria ("blackwater fever" in severe P. falciparum)
Chest X-ray	If pulmonary oedema (ARDS) suspected
Lumbar puncture	If cerebral malaria vs bacterial meningitis cannot be distinguished

6. Species Identification - Key Microscopy Differentials

Feature	P. falciparum	P. vivax	P. ovale	P. malariae
RBC size	Normal or small	Enlarged	Slightly enlarged	Normal or small
Schüffner's dots	Absent (Maurer's clefts instead)	Present	Present	Absent
Trophozoite	Delicate ring, often multiple per RBC, "appliqué" (accolé) position	Amoeboid, irregular	Compact	Band form
Gametocyte	Crescent/banana-shaped (pathognomonic)	Round/oval	Round/oval	Round
Max. merozoites in schizont	8-24	12-24	6-12	6-12

7. Approach by Clinical Setting

Where microscopy is available within 24 hours: Use smear as primary test, treat according to species identified.

Where microscopy is delayed and monovalent RDT (PfHRP2) is used: Treat positive as P. falciparum; if negative and symptoms persist, arrange microscopy.

Where bivalent RDT (PfHRP2 + pan) is used: Can distinguish falciparum from non-falciparum and guide treatment accordingly. (Park's Preventive Medicine, p.308)

In the United States: The CDC Malaria Hotline is available for guidance: (770) 488-7100 after hours / (855) 856-4713 toll-free. Smear is mandatory even if RDT is performed - results should be available as soon as possible. (Sherris & Ryan Medical Microbiology 8E, Fig. 51-7)

Summary Flow

Fever + travel to endemic area
         ↓
Thick + thin blood smear (Giemsa, ×1000)
         ↓
Positive → species ID + count parasitemia → guide treatment
Negative → repeat smear every 12-24h × 3 if clinical suspicion remains
         ↓
If microscopy unavailable → RDT immediately
         ↓
All positives → smear when possible to confirm species + density
         ↓
PCR if species uncertain or mixed infection suspected

This is a shared conversation. Sign in to Orris to start your own chat.